HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    
What's Up With These Ridiculous Stock Gains?

Steve Reitmeister didn't want me to tell you this. He felt that one strategy's performance stands out so much that... Read on >>
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

EW: Edwards Lifesciences Corp - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
EDWARDS LIFESCIENCES CORP (NYSE)
EW 82.25 N/A (N/A%) Vol.  0 N/A ET
Edwards Lifesciences Corp. a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately hundred countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the United States Patent and Trademark Office.

 General Information
EDWARDS LIFESCI
One Edwards Way
Irvine, CA 92614
Phone: 949 250-2500
Fax: 949-250-2525
Web: www.edwards.com
Email: investor_relations@edwards.com
 
Industry MED PRODUCTS
Sector: Medical
 
Fiscal Year End December
Last Reported Quarter 09/30/09
Next EPS Date 02/09/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 82.25
52 Week High 82.45
52 Week Low 45.06
Beta 0.46
20 Day Moving Average 394,483.75
Target Price Consensus 76.65
 
 % Price Change
4 Week 6.91
12 Week 30.80
YTD 47.86
 % Price Change Relative to S&P 500
4 Week 5.75
12 Week 23.31
YTD 22.37
 Share Information
Shares Outstanding (millions) 56.42
Market Capitalization (millions) 4,584.04
Short Ratio 5.23
Last Split Date N/A
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 0.84
Current Year EPS Consensus Estimate 3.05
Estimated Long-Term EPS Growth Rate 15.80
Next EPS Report Date 02/09/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 2.22
30 Days Ago 2.11
60 Days Ago 2.11
90 Days Ago 2.42

 Fundamental Ratios
 P/E
Current FY Estimate: 26.65
Trailing 12 Months: 27.08
PEG Ratio 1.69
 EPS Growth
vs. Previous Year 26.79%
vs. Previous Quarter -12.35%
 Sales Growth
vs. Previous Year 7.28%
vs. Previous Quarter: -2.92%
 Price Ratios
Price/Book 4.20
Price/Cash Flow 21.97
Price / Sales 3.57
 ROE
09/30/09 17.93
06/30/09 18.01
03/31/09 17.60
 ROA
09/30/09 12.05
06/30/09 11.89
03/31/09 11.52
 Current Ratio
09/30/09 2.96
06/30/09 3.04
03/31/09 3.24
 Quick Ratio
09/30/09 2.39
06/30/09 2.39
03/31/09 2.51
 Operating Margin
09/30/09 13.66
06/30/09 13.20
03/31/09 12.60
 Net Margin
09/30/09 21.49
06/30/09 17.86
03/31/09 17.12
 Pre-Tax Margin
09/30/09 21.49
06/30/09 17.86
03/31/09 17.12
 Book Value
09/30/09 19.33
06/30/09 17.91
03/31/09 16.88
 Inventory Turnover
09/30/09 2.53
06/30/09 2.67
03/31/09 2.86
 Debt-to-Equity
09/30/09 0.09
06/30/09 0.11
03/31/09 0.13
 Debt to Capital
09/30/09 8.58
06/30/09 10.20
03/31/09 11.53

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research